US EditionBioNTech: Vaccine Manufacturer Share Depends on Crypto Market
Summary by BTC-ECHO
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
All
Left
Center
Right
During the Corona crisis, the Biontech share was in huge demand. The balance sheet is sobering. Currently, a new cancer drug drives the share price. Should one buy Biontech now or sell with profit?
The securities of the Mainz-based pharmaceutical company have recently really shot up and provided investors with crypto-like profits. Bitcoin is now in wait. Source: BTC-ECHO BTC-ECHO
Coverage Details
Total News Sources2
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
